Form 4 holding
Senior Advisor to the Chief Executive Officer
Revolution Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 286,307
- Estimated value
- $57,061,901
- Report date
- 16 Sep 2026
- Price
- $199.30
- Ownership
- Direct